Table 4 The prescription dose, conformity index (CI), heterogeneity index (HI) and the number of monitor units (MU) in the anatomical and functional IMRT plans for the 11 patients
Patient | Diagnosis | Prescription dose (cGy) | PTV (cm3) | Anatomic planning | Functional planning | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PTV | PTV | ||||||||||
90%CI | HI | MU | Mean (%) | 90%CI | HI | MU | Mean (%) | ||||
1 | NSCLC | 6000 | 62.1 | 0.34 | 0.08 | 741 | 102.6 | 0.31 | 0.11 | 999 | 102.6 |
2 | NSCLC | 7400 | 119.5 | 0.68 | 0.07 | 387 | 101.9 | 0.62 | 0.10 | 724 | 101.9 |
3 | Thymoma | 5400 | 216.7 | 0.56 | 0.10 | 513 | 102.3 | 0.53 | 0.15 | 605 | 102.3 |
4 | SCLC | 5400 | 253.5 | 0.56 | 0.14 | 551 | 102.2 | 0.47 | 0.13 | 1182 | 102.2 |
5 | Thymoma | 5040 | 260.7 | 0.57 | 0.12 | 517 | 102.4 | 0.52 | 0.15 | 705 | 102.4 |
6 | Esophagus | 5040 | 393.2 | 0.64 | 0.11 | 734 | 102.4 | 0.75 | 0.13 | 790 | 102.4 |
7 | NSCLC | 5000 | 639.8 | 0.66 | 0.14 | 1060 | 100.9 | 0.64 | 0.11 | 1163 | 100.9 |
8 | Esophagus | 5040 | 660.6 | 0.61 | 0.12 | 960 | 102.5 | 0.40 | 0.12 | 973 | 102.5 |
9 | NSCLC | 5000 | 716.6 | 0.67 | 0.09 | 867 | 101.9 | 0.60 | 0.13 | 1291 | 101.9 |
10 | Esophagus + NSCLC | 5040 | 732.8 | 0.67 | 0.09 | 962 | 102.0 | 0.66 | 0.12 | 1074 | 102.0 |
11 | NSCLC | 6000 | 804.9 | 0.61 | 0.10 | 1367 | 101.1 | 0.47 | 0.12 | 1302 | 101.1 |